Timing of Cortiment (Budesonide) Response in IBD Flares
You should expect symptomatic improvement from Cortiment (budesonide) 9 mg daily within 2-4 weeks, with full remission typically achieved by 8 weeks of treatment. 1
Expected Timeline for Response
Early Symptomatic Relief (2-4 Weeks)
- Clinical trials consistently show median time to symptomatic remission around 3-4 weeks 1
- Significant improvement over placebo is evident as early as 2 weeks in controlled studies 1
- Approximately 20% of patients achieve remission within 3-4 weeks of starting therapy 1
Full Treatment Course (8 Weeks)
- The standard treatment duration is 8 weeks for induction of remission 2
- Response rates plateau around 8 weeks, with approximately 51% of patients achieving clinical remission (CDAI <150) by this timepoint 2
- After achieving remission, budesonide should be tapered over 1-2 weeks 2
When to Reassess Treatment
Evaluate for symptomatic response between 4-8 weeks to determine if therapy modification is needed 1. This assessment window is critical because:
- If no improvement is evident by 4-8 weeks, consider escalating to systemic corticosteroids (prednisolone 40-60 mg daily) 1
- Any worsening of symptoms during the therapeutic trial requires immediate reevaluation 1
- In patients with severe disease (CDAI >300), budesonide is inferior to prednisolone and should not be used 2
Important Caveats
Disease Location Matters
- Cortiment is only effective for ileocaecal and right colonic Crohn's disease 2, 1
- There is no evidence of benefit for distal colonic inflammation 2
- For colonic Crohn's disease beyond the proximal colon, systemic corticosteroids are required 2
Disease Severity Limitations
- Budesonide is appropriate only for mild to moderate disease 2, 1
- For moderate to severe disease, systemic corticosteroids should be used from the outset 1
- The 2025 British Society of Gastroenterology guidelines now recommend evaluating response at 2 weeks with clinical and/or biomarker assessment (fecal calprotectin) to enable timely escalation if needed 3
Not for Maintenance
Budesonide should not be used for maintenance of remission 1. Once remission is achieved, taper over 1-2 weeks and transition to appropriate maintenance therapy 2.
Practical Algorithm
- Start budesonide 9 mg once daily (as effective as 3 mg three times daily) 2, 4
- Assess at 2 weeks: Look for any symptomatic improvement or check fecal calprotectin 3
- Reassess at 4-8 weeks: Determine if adequate response achieved 1
- If inadequate response by 4-8 weeks: Switch to systemic corticosteroids or consider advanced therapies 1, 3
- If remission achieved: Taper over 1-2 weeks and initiate maintenance therapy 2
The key is not to continue ineffective therapy indefinitely—if clear improvement isn't evident within the 4-8 week window, escalation is warranted 1.